معرفی
Iveta Ozere is an Associate Professor at the Department of Infectology, Riga Stradins University, Latvia. She is actively engaged in research and clinical studies related to tuberculosis, focusing on molecular diagnostics, drug resistance, pharmacogenomics, and host-pathogen interactions. Her work is supported by national grants from the Latvian Council of Science and RSU, and she leads and participates in multidisciplinary research projects.
- PhD, Riga Stradins University (implied from academic rank and research activity)
- Expert in Clinical Medicine (Field 3.2), Latvian Council of Science (2018–2027)
Her research interests center on clinical tuberculosis, with emphasis on genetic polymorphisms affecting drug metabolism, whole genome sequencing for tracking transmission and resistance, and biomarkers of lung damage and treatment response. She explores how variations in genes like NAT2, GSTM1, CYP2E1, and AADAC influence drug pharmacokinetics and toxicity, aiming to personalize TB therapy. Her work also investigates cytokine dynamics, CRP reduction patterns, and endogenous reactivation using advanced genomic tools.
The recent publications show a strong trend toward integrating genomics, pharmacokinetics, and clinical outcomes in pulmonary TB. Topics include discordance between phenotypic and WGS-based drug susceptibility, mutation rates in M. tuberculosis, and the role of host genetics in treatment response. These studies contribute to more precise, individualized approaches in TB management and diagnostics.
She has contributed to policy and public understanding through invited talks and media engagement, including commentary on BCG vaccine implications during the pandemic. Her work aligns with UN Sustainable Development Goal 3 (Good Health and Well-being).
Dr. Ozere supervises students and early-career researchers, including A. Saliņa and L. Setlere, and is involved in grants such as the Latvian Council of Science’s Fundamental and Applied Research Programme. She collaborates extensively with experts like A. Vīksna, D. Sadovska, and R. Ranka.
She is active in professional networks, presenting at conferences and workshops, and contributing to national and international discussions on TB management, particularly in pediatric settings and diagnostic innovation.
